Skip to main content
Clinical Trials/NCT06067867
NCT06067867
Recruiting
Not Applicable

Kidney and Pregnancy Registry

Brugmann University Hospital1 site in 1 country600 target enrollmentSeptember 12, 2023
ConditionsKidney Diseases

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Kidney Diseases
Sponsor
Brugmann University Hospital
Enrollment
600
Locations
1
Primary Endpoint
Clinico-biological characteristics of patients
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Maternal physiological adaptation to pregnancy plays an important role in the smooth progress of the pregnancy and the healthy growth of the fetus. This physiological adaptation takes place at the level of several organs, including the kidney. Physiological changes during a normal pregnancy take place at the anatomical, glomerular and tubular level.

In the event of pre-existing kidney damage (glomerular and tubular diseases, stone disease, high blood pressure (hypertension) etc...) these adaptations will not be optimal. This will have implications for:

  • the course of the pregnancy with the occurrence of feto-maternal complications: miscarriages, pre-eclampsia, intrauterine growth retardation (IUGR), low birth weight, prematurity. The risk of feto-maternal complications increases with the degree of renal failure or with certain pathologies such as lupus.
  • progression of kidney disease

Some maternal complications have long-term implications: preeclampsia is associated with a high risk of subsequent cardiovascular and renal complications. Pregnancies in these patients are high-risk pregnancies and require specialized management by an experienced group of gynecologists and nephrologists.

The creation of a retrospective and prospective register by collecting demographic, clinical, biological, radiological and genetic data concerning patients at each consultation within the CHU Brugmann Hospital will allow:

  • to establish the epidemiological and clinico-biological characteristics of the patients followed at the Kidney and Pregnancy Clinic at the CHU Brugmann Hospital
  • to analyze the risk factors for feto-maternal complications
  • to analyze the risk factors for the occurrence of subsequent cardio-renal pathologies in patients who have had preeclampsia or an event during their pregnancy
  • to identify patients who will need specialized genetic testing
Registry
clinicaltrials.gov
Start Date
September 12, 2023
End Date
December 2043
Last Updated
2 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Tatiana Besse-Hammer

Head of clinical research unit

Brugmann University Hospital

Eligibility Criteria

Inclusion Criteria

  • Pre-conception consultations
  • Woman of childbearing age with:
  • Renal damage (glomerular, tubular disease, renal lithiasis, systemic disease, metabolic diseases, congenital diseases, etc.)
  • Hematological disorders (sickle cell disease)
  • Kidney transplantation
  • High blood pressure (hypertension)
  • Pre-kidney transplant assessment in progress for discussion of contraception and pregnancy after kidney transplantation
  • Preeclampsia
  • Multiple miscarriages
  • IUGR and low birth weight in the fetus

Exclusion Criteria

  • Male patients Menopausal patients

Outcomes

Primary Outcomes

Clinico-biological characteristics of patients

Time Frame: 20 years

Risk factors for cardio-renal pathologies

Time Frame: 20 years

Risk factors for the occurrence of subsequent cardio-renal pathologies in patients who had preeclampsia or an event during their pregnancy

Need for genetic testing

Time Frame: 20 years

Identification of patients who will need specialized genetic testing

Risk factors for feto-maternal complications

Time Frame: 20 years

Epidemiological characteristics of patients

Time Frame: 20 years

Study Sites (1)

Loading locations...

Similar Trials